To hit the research bullseye, you need precision. That’s why we optimize our recombinant antibodies to give you unrivaled specificity and consistency every time. https://lnkd.in/emKi-Un
About us
At Abcam, we believe the scientific community goes further, faster when we go there together. And to keep on making ground-breaking discoveries, we need to work together in new ways. That’s why we’re constantly innovating to help scientists drive their research forward by providing products and solutions that play an essential role in fundamental research, drug discovery, diagnostic and therapeutic applications. We started with a simple mission: to provide the best biological reagents to life scientists worldwide. Today, we help 750,000 researchers in over 130 countries deliver faster breakthroughs in areas like cancer, neurological disorders, infectious diseases, and metabolic disorders. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health. Abcam is proud to be part of Danaher. Danaher is a global science and technology leader. Together we combine our capabilities to accelerate the real-life impact of tomorrow’s science and technology to improve human health.
- Website
-
https://www.abcam.com/
External link for abcam
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Cambridgeshire
- Type
- Public Company
- Specialties
- antibodies, custom services, proteins, gene-edited cell lines, knockout cell lines, rabbit antibodies, immunoassays, biological reagents, monoclonal antibodies, research, drug discovery , diagnostics, RabMAb, and Life Sciences
Locations
Employees at abcam
Updates
-
“One of the best feelings in science is seeing new data… Something that hasn’t been discovered or shown by anyone else”. - Graham Heieis, EPISODE OUT NOW! Hear how Graham came to be solving one of the world’s largest health burdens. In abcam's new short film series, Love Letters to Science, part five launches with Graham’s story of how he fell in love with science. Watch the full episode here: https://bit.ly/3QOcQBV #ProgressHappensTogether #Abcam #LoveLettersToScience
-
April is Parkinson's Awareness Month, and we're spotlighting the incredible work of Nicole Polinksi and Elisia Clark, both scientists-turned-connectors at The Michael J. Fox Foundation for Parkinson's Research (MJFF). With a collaborative approach, they bridge the gap between researchers, tools, and funding to accelerate critical studies on Parkinson's disease. Read their story here: https://lnkd.in/eV4f6FVT #ParkinsonsMonth #ParkinsonsAwarenessMonth
-
📢 Exciting announcement! The Cell Cycle Conference returns on June 4 for our summer meeting at the Francis Crick Institute, London, and live-streamed for virtual attendees. Join us for an afternoon of insights into novel research findings, with a featured talk by Prof. Fumiko Esashi from the Sir William Dunn School of Pathology, University of Oxford. 📝 #CallforAbstracts: showcase your innovative research to a community of like-minded #cellcycle researchers. Short talk and poster opportunities are available to in-person attendees. Submit an abstract by May 17! https://bit.ly/3WeTidj
-
Today is International Day of Immunology! Check out this ground-breaking research from Graham Heieis & team on the immune response to helminths – one of the world’s most troubling parasitic infections. Dive deeper into Graham's passion for his work in his #LoveLetterstoScience film - out Wednesday! https://lnkd.in/e_xGH4pc #DOI2024 #Immunology
-
Our next Inflammazoom webinar is just around the corner ➡ Register for free to join our global network of immunologists on April 29 and hear fascinating talks on #immunometabolism control by #NLRP3 #inflammasome activation by Pablo Pelegrin, University of Murcia, Biomedical Research Institute of Murcia, Spain and Olaf Groß, University Medical Center Freiburg, University of Freiburg, Germany. Click the link to learn more and register now. https://bit.ly/4dgEZLu
-
Looking for opportunities to grow and develop in your career? 💼✨ Meet Simon Pascoe, our Finance Business Partner, whose journey with Abcam started over a decade ago. His story is a testament to the endless possibilities that await those with drive and determination. 💪 Simon's journey began as a part-qualified accountant in Cambridge, UK, supporting our R&D and Manufacturing teams. Fast forward to today, he's traveled the world, seized every opportunity for growth, and now works alongside our Sales and Marketing teams. His advice to those considering joining our community? 🔹 Be proactive: Don't wait for opportunities, actively pursue them. 🔹 Embrace challenges: Each one is a chance to grow. 🔹 Value mentorship: It can change your career trajectory. Simon's story is just one of many at Abcam. If you're ready to embark on a journey of growth and development, we want to hear from you! 🌟 Read the full blog article here: https://lnkd.in/ei2UGfyR #Abcam #CareerGrowth #GrowingwithAbcam #CareersinSTEM
-
“For me, it’s also really just about the mystery of it and solving that puzzle”. Graham Heieis from Leiden University Medical Centre inherited a good memory from his grandmother and has put it to the test throughout his career in immunology. In a new series of short films, Love Letters to Science, we’re exploring five scientists' passionate relationship to their research, and how it helped them find their collaborations, people and community. Graham’s episode is out MAY 1! #ProgressHappensTogether #Abcam #LoveLettersToScience #PeopleBehindTheScience
-
“You can find your lane in shipping. You can find your lane in procurement. There’s so many avenues to go within biotechnology.” Josiah Wade-Green is a recent graduate of Bioversity's Biotech Career Foundations program – a new initiative from MassBio to create new career pathways in STEM. Now a logistics technician at Abcam, he’s helping get critical tools to researchers around the world. Read his story here: https://lnkd.in/euCzFeZp